Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 679-689    DOI: 10.12891/ceog4889.2019
Review Previous articles | Next articles
MSOME and IMSI: reasonable rationale, selective clinical value
I. Gat1, 2, 3, 4, G. Raviv2, 4, 5, M. Baum1, 2, R. Orvieto1, 2, 6, *()
1Infertility & IVF Unit, Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Tel Hashomer, Israel
4Andrology Unit, Sheba Medical Center, Tel Hashomer, Israel
5Urology Department, Sheba Medical Center, Tel Hashomer, Israel
6The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel Aviv, Israel
Download:  PDF(421KB)  ( 309 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      

Purpose: Motile sperm organelle morphology examination (MSOME) is a real-time high magnification motile sperm examination applied prior to intracytoplasmic morphologically selected sperm injection (IMSI) - intracytoplasmic injection of the selected spermatozoon. Over the past decade, there is an important shift concerning MSOME, focusing on the shape of the sperm head and presence of vacuoles, resulting with different selection criteria. The authors investigated the relevance of sperm vacuoles phenomenon. From a clinical perspective they focused on prospective trials aiming to distinguish scenarios in which IMSI may improve clinical outcome compared with intracytoplasmic sperm injection (ICSI). Materials and Methods: The authors performed this review based on a primary literature search of publications, which as of November 1, 2017, were listed in PubMed under the search phrase <motile-sperm organelle morphology examination>, <MSOME>, <intra-cytoplasmic morphologically selected sperm injection>, <IMSI>, and <sperm vacuoles>. The references of these manuscripts were further reviewed when considered relevant to the subject. Results: Inadequate chromatin compaction leads to higher rate of DNA fragmentation and aneuploidies, which may be followed by the appearance of large vacuoles. Distinguishing between large and small vacuoles remains a challenge. IMSI may expand blastocyst formation in cases of previous embryos developmental arrest and may be used in cases of isolated teratospermia and repetitive ICSI cycles failures. Conclusions: Solid evidence supports the association between non-adequate sperm DNA compaction and DNA defects, resulting with abnormal vacuoles. Current prospective studies emphasize ICSI as first treatment for male factor during assisted reproductive technology (ART), while the role of IMSI in selective clinical scenarios warrants further large randomized controlled studies.

Key words:  MSOME      IMSI      ICSI      Male factor     
Published:  10 October 2019     
*Corresponding Author(s):  R. ORVIETO     E-mail:

Cite this article: 

I. Gat, G. Raviv, M. Baum, R. Orvieto. MSOME and IMSI: reasonable rationale, selective clinical value. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 679-689.

URL:     OR

[1] M. Elmahdy, I. Elfourtia, H. Maghraby. Office hysteroscopy in cases of recurrent implantation failure; Do or not to do[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 723-728.
[2] Sh. Gaafar, T. Hanafy, S. El Morshedy, H. Mansour. Effect of extended embryo culture after thawing on clinical pregnancy rate[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 764-768.
[3] H. Ye, S. Xue1, Y. Kuang, L. Sun. A patient with non-mosaic 47, XXY karyotype fathering a normal healthy infant using intracytoplasmic sperm injection (ICSI) - a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 309-311.
[4] P. Bakas, M. Simopoulou, P. Panagopoulos, N. Salakos, Ch. Siristatidis. Luteal phase progesterone and estradiol concentrations and their relation to the outcome of IVF/ICSI cycles with controlled ovarian stimulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 727-730.
[5] S.A. Hebisha, Hisham M. Adel. Impact of the oxytocin receptor antagonist atosiban administered shortly before embryo transfer on pregnancy rates after ICSI[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 513-516.
[6] T. Miyamoto, K. Abiko, A. Itabashi, G. Minase, H. Ueda, K. Sengoku. MD-TESE-ICSI using fresh sperm resulted in a lower rate of miscarriage compared with frozen-thawed sperm[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 229-230.
[7] P. Bakas, M. Creatsa, P. Panagopoulos, N. Vlahos, E. Papadakis, M. Simopoulou. Outcome and recurrence risk of premature progesterone rise in IVF/ICSI cycles using GnRH antagonists for pituitary down-regulation[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 44-47.
[8] A.J. Jakimiuk, M.A. Nowicka, M. Zagozda, K. Koziol, P. Lewandowski, T. Issat. Levels of EG-VEGF and VEGF in serum and in the follicular fluid on the day of oocyte retrieval and reproductive outcome among IVF patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 93-97.
[9] A.G. Zebitay, T. Irez, T.A. Usta, S. Karahuseyinoglu, E. Oral, S. Sahmay, O. Çetin. Is early embryo cleavage a factor to increase success in all types of ICSI indications?[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 353-358.
[10] S. Liapi, S. Polychronopoulou. Cognitive and socio-emotional development and manifestation of learning disabilities of 8- to 10-year-old children born after intracytoplasmatic sperm injection compared to naturally conceived children[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(1): 104-109.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .